A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for Treatment of Plaque Psoriasis in Adults
Status:
Withdrawn
Trial end date:
2019-01-01
Target enrollment:
Participant gender:
Summary
This trial will be a double-blind, single-center, randomized, placebo controlled study to
evaluate the safety, tolerability, and efficacy of SAN021 study drug when administered for up
to 42 days to adults between the ages of 18 to 65 years who have a clinical diagnosis of
mild-to-moderate plaque psoriasis.